AZN
AstraZeneca PLC
Latest News for AZN
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new ROMEO study tracks how safe its COPD drug tozoraki......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is running a first-in-human trial named “Phase I/II Dose......
Shares in drugmakers Pfizer ($PFE), Eli Lilly ($LLY), and Novo Nordisk ($NVO) edged lower on Monday afternoon after CNBC’s Megan Cassella revealed ......
Shares in drugmakers Pfizer ($PFE), Eli Lilly ($LLY), and Novo Nordisk ($NVO) edged lower on Monday afternoon after CNBC’s Megan Cassella revealed ......
An update from AstraZeneca ( ($GB:AZN) ) is now available. AstraZeneca and Daiichi Sankyo have secured U.S. FDA approval for two new indications of......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new SECURE study, officially titled “Cross-sectional Q......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is running a chart review study in China called “A Multi......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The PREDICT study, officially titled “A Prospective, Multicenter Rea......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is running a new real‑world study called “Effectiveness ......
In a report released today, Emmanuel Papadakis from Deutsche Bank reiterated a Sell rating on AstraZeneca, with a price target of p11,500.00. Accor......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 22 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AZN | $188.45 | +0.8% | 738.20K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |